GlassScriptPhysician profile
Michelle Wong
NPI 1679912539
$641.49
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $164 · 2023: $272 · 2024: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $115.00 | 2022-2024 | Rinvoq, Linzess, Creon |
| Boston Scientific Corporation | $89.67 | 2022 | |
| Ardelyx, INC. | $67.05 | 2023-2024 | Ibsrela |
| Pfizer INC. | $64.55 | 2023-2024 | |
| Janssen Biotech, INC. | $57.70 | 2022-2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.91 | 2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $56.79 | 2022-2023 | Entyvio |
| Genzyme Corporation | $34.57 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $32.66 | 2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $28.54 | 2024 | |
| Ferring Pharmaceuticals INC. | $22.84 | 2024 | Rebyota |
| Lilly USA, LLC | $15.21 | 2024 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.